Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 02 Nov 2026 for Regeneron Pharmaceuticals, INC., €18.2M.
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
No signal scores available.
George L. Sing: trading record in brief
Only one filing by George L. Sing is known so far (2 November 2026): a transaction, €18.2M, in Regeneron Pharmaceuticals, Inc. That is too little to draw conclusions. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to George L. Sing
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
- 21,129 shares@ US$964.37880.021% mcap100.0% of flowCommonSEC144:0001950047-26-010543
1 of 1 declaration
